Novel Method Development Approaches for Peptide Analysis in Doping
By attending this presentation, you will learn:
- Peptide analysis method development via the presentation of experiment results
- An understanding of the Biotage sample preparation workflow and the benefits of automation
Event Overview
An overview of sample preparation approaches for the analysis of World Anti-Doping Agency (WADA) prohibited peptides from urine samples on LC-HRMS (Liquid Chromatography-High Resolution Mass Spectrometry).
The webinar will discuss sample preparation method development approaches undertaken to extract a panel of peptides using the full Biotage workflow. We will address the encountered challenges during development and share insights into optimizing recoveries and ensuring reproducibility for a range of analytes. We will also highlight the benefits of automating these methods to ensure reproducible analysis and free up laboratory analysts' time for other important laboratory tasks.
The webinar is aimed at human and animal sport doping laboratories interested in preparing biofluids for peptide analysis. Attendees will benefit from a deepened understanding of how to achieve clean samples with reproducible results, thereby empowering laboratories to maintain the highest standards of analytical excellence in the field of anti-doping testing.
What you need to know:
Broadcast #1: 6 June - 10 am BST (London) / 11 am CEST (Paris/Berlin) / 2:30 pm IST (New Delhi) / 5 pm SGT (Singapore)
Broadcast #2: 6 June - 10 am PDT (Los Angeles) / 12 pm CDT (Chicago) / 1 pm EDT (New York)
Presenter: Thomas Smith (EU Applications Team Leader, Biotage)
Thomas has been with Biotage since July 2022 and is supporting customers to improve and streamline their sample preparation approaches and helping them automate their manual, labor-intensive tasks in the laboratory. Before this role, Thomas worked in a toxicology lab analyzing hair for drugs of abuse and alcohol markers. His main role here was to automate a method to increase reproducibility and turnaround time to meet the growing sample numbers.
